To discuss the company's business strategy and corporate overview.

Neurologix Inc. expected to Report Q3 2009 Results on November 9, 2009. This event was calculated by Capital IQ (Created on August 13, 2009).

Neurologix Inc. announced unaudited consolidated financial results for the second quarter and six months ended June 30, 2009. For the quarter, the company reported a net loss applicable to common stock of $3.0 million or $0.11 per basic and diluted share, as compared with a net loss applicable to common stock of $2.8 million, or $0.10 per basic and diluted share, for the same period in 2008. The net loss applicable to common stock includes charges of $0.7 million, or $0.03 per basic and diluted share, related to preferred stock dividends in connection with the company's Series D Convertible Preferred Stock and the company's Series C Convertible Preferred Stock, compared to the net loss applicable to common stock includes charges of $1.4 million, or $0.05 per basic and diluted share, for the three months ended June 30, 2008 related to the accretion of beneficial conversion features ($0.8 million) in connection with the issuance of the Series D Stock in April 2008, as well as preferred stock dividends ($0.6 million) in connection with the Series D Stock and the Series C Stock. Loss from operations was $5.2 million compared to $3.6 million a year ago. For the six months, the company reported net loss applicable to common stock of $8.6 million or $0.31 per basic and diluted share, as compared with $5.3 million or $0.19 per basic and diluted share, for the same period in 2008. The net loss applicable to common stock includes charges of $1.5 million or $0.05 per basic and diluted share, related to preferred stock dividends in connection with the Series D Stock and the Series C Stock. For the six months ended June 30, 2008, the net loss applicable to common stock includes charges of $2.0 million or $0.07 per basic and diluted share, related to the accretion of beneficial conversion features ($0.8 million) in connection with the issuance of the Series D Stock in April 2008, and preferred stock dividends ($1.2 million) in connection with the Series D Stock and the Series C Stock. Loss from operations was $3.1 million compared to $1.6 million a year ago.